Our strategy and technology consultants have empowered our international clients with the knowledge and experience they need to build their own local resources and capabilities.
In facing challenges of modernization, our Middle East and North Africa clients have complex requirements that benefit from our proven experience in guiding major programs and projects for governments and private-sector organizations. The services we offer in UAE, Qatar, Saudi Arabia, Egypt, Turkey, Kuwait, Morocco, Jordan, and other regional countries build on our consulting legacy.
Our clients call upon us to work on their hardest problems—delivering effective health care, protecting warfighters and their families, keeping our national infrastructure secure, bringing into focus the traditional boundaries between consumer products and manufacturing as those boundaries blur.
Booz Allen was founded on the notion that we could help companies succeed by bringing them expert, candid advice and an outside perspective on their business. The analysis and perspective generated by that talent can be found in the case studies and thought leadership produced by our people.
Learn more about Booz Allen's diverse culture and environment of inclusion that fosters respect and opportunity for all employees.
We've come a long way delivering innovative solutions. But our next chapter is still being written.
Our 22,600 engineers, scientists, software developers, technologists, and consultants live to solve problems that matter. We’re proud of the diversity throughout our organization, from our most junior ranks to our board of directors and leadership team.
Booz Allen takes pride in a culture that encourages and rewards the many dimensions of leadership—innovative thinking, active collaboration, and personal service. We’re particularly proud of the diversity of our Leadership Team and Board of Directors, among the most diverse in corporate America today.
Most pharmaceutical companies agree that the losses from a cyber attack could be staggering. Consequences ranging from stolen IP, repeating clinical trials, litigation, and lost revenue resonate throughout an organization. Although the pharmaceutical industry is lagging behind other industries when it comes to cybersecurity implementation, there’s a new sense of urgency. Because of the impact to share prices and brand image, boards of directors have taken note. As data sharing becomes more prevalent across the industry, companies are starting to grasp that a breach in their network—that subsequently spreads to others—could have significant reputational impact.
Pharmaceutical companies must understand the risks and vulnerabilities within their firms as well as third party exposure. In this Business Insight, Booz Allen Hamilton Senior Lead Technologist Lou Klubenspies discusses today’s most important cybersecurity issues facing the pharmaceutical industry and how to address them.
“Number 3: Adversaries are looking for your most valuable and sensitive data like formulas and compounds.”
Learn more about the cybersecurity issues impacting the pharmaceutical industry, and what you can do to prepare and protect your company.